This document provides information on various types of meningitis and encephalitis. It begins by describing the typical presentation of bacterial meningitis, including fever, headache, and meningismus. It then discusses the most common causative organisms of bacterial meningitis according to age. The diagnostic evaluation and treatment of bacterial meningitis is also outlined. Tuberculous meningitis is then reviewed, including its pathogenesis, clinical features, diagnosis and treatment approach. Finally, the document briefly discusses various viral causes of meningitis and encephalitis.
1. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and affects mostly the lungs. It is both preventable and curable.
2. The most common age group affected is 15-45 years old. Factors that increase the burden of TB include HIV, poor socioeconomic status, poor nutrition, and limited access to healthcare.
3. TB treatment aims to cure patients, prevent transmission and death, and prevent drug resistance. Treatment follows principles of using multiple drug combinations under direct observation to ensure adherence and prevent resistance.
Tuberculosis (TB) can be diagnosed through a combination of tests including the tuberculin skin test (TST), chest x-ray, and analysis of bodily fluids or tissues. TST detects exposure to TB but does not confirm active disease. Chest x-ray may show abnormalities indicative of TB. Sputum, pleural fluid, cerebrospinal fluid, or tissue samples can be examined for acid-fast bacilli or cultured to identify Mycobacterium tuberculosis. New diagnostic tools like interferon-gamma release assays and the Xpert MTB/RIF nucleic acid test have improved TB diagnosis. A history of symptoms, risk factors, and test results together are used to diagnose TB.
Abdominal Tuberculosis final final.pptxmanjujanhavi
Abdominal tuberculosis is a common extra-pulmonary manifestation of tuberculosis. It can affect any part of the gastrointestinal tract, with the ileocecal region being the most common site. Presentations include intestinal obstruction, perforation, ascites, and masses. Diagnosis involves imaging such as x-ray, ultrasound and CT scan. Laboratory tests on ascitic fluid include ADA levels, smear and culture. Laparoscopy allows for biopsy and diagnosis. Treatment involves anti-tuberculosis medication alongside management of complications. Coinfection with HIV increases severity and risk of immune reconstitution inflammatory syndrome.
Abdominal tuberculosis is a common extra-pulmonary manifestation of tuberculosis. It can affect any part of the gastrointestinal tract, with the ileocecal region being the most common site. Presentations include intestinal obstruction, perforation, ascites, and masses. Diagnosis involves imaging such as x-ray, ultrasound and CT scan. Laboratory tests on ascitic fluid include ADA levels, smear and culture. Laparoscopy allows for biopsy and diagnosis. Treatment involves anti-tuberculosis medication alongside management of complications. Coinfection with HIV increases severity and risk of immune reconstitution inflammatory syndrome.
This document discusses tuberculosis of the hip. It begins by providing historical context, noting that Robert Koch discovered Mycobacterium tuberculosis in 1882. It then discusses the pathogenesis and presentation of hip TB. Key points include that hip TB is secondary to a primary focus that spreads hematogenously to the hip. Presenting symptoms often include pain and limping. The document outlines the typical pathology and stages of hip TB from synovitis to advanced arthritis and destruction of the joint. Diagnosis involves clinical, radiological, bacteriological and molecular testing. Management includes antitubercular therapy, rest, traction and sometimes surgical interventions like excision arthroplasty or joint replacement.
The document discusses the evaluation and diagnosis of pyrexia of unknown origin (PUO). It defines PUO and provides classifications. The most common causes are infections (30-40%), neoplasms (20-30%), and non-infectious inflammatory conditions (10-20%). The initial approach involves thorough history, physical exam, and basic lab tests. Further targeted testing is based on clues from initial evaluation and may include specialized cultures, biopsies, and imaging. The goal is to methodically consider and rule out more likely causes through an intensive diagnostic process to identify the underlying condition.
1. Clinical manifestations of paediatric tuberculosis can be non-specific and tuberculosis is more difficult to diagnose in children compared to adults. Children are more likely to develop severe or disseminated disease if tuberculosis is undiagnosed or untreated.
2. Diagnosis of tuberculosis in a child is a sentinel event that requires contact investigation to be critical.
3. Congenital tuberculosis transmission from mother to child is rare but carries high risks of neonatal mortality and morbidity, so early diagnosis and treatment of infected newborns is important.
This document provides information on various types of meningitis and encephalitis. It begins by describing the typical presentation of bacterial meningitis, including fever, headache, and meningismus. It then discusses the most common causative organisms of bacterial meningitis according to age. The diagnostic evaluation and treatment of bacterial meningitis is also outlined. Tuberculous meningitis is then reviewed, including its pathogenesis, clinical features, diagnosis and treatment approach. Finally, the document briefly discusses various viral causes of meningitis and encephalitis.
1. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and affects mostly the lungs. It is both preventable and curable.
2. The most common age group affected is 15-45 years old. Factors that increase the burden of TB include HIV, poor socioeconomic status, poor nutrition, and limited access to healthcare.
3. TB treatment aims to cure patients, prevent transmission and death, and prevent drug resistance. Treatment follows principles of using multiple drug combinations under direct observation to ensure adherence and prevent resistance.
Tuberculosis (TB) can be diagnosed through a combination of tests including the tuberculin skin test (TST), chest x-ray, and analysis of bodily fluids or tissues. TST detects exposure to TB but does not confirm active disease. Chest x-ray may show abnormalities indicative of TB. Sputum, pleural fluid, cerebrospinal fluid, or tissue samples can be examined for acid-fast bacilli or cultured to identify Mycobacterium tuberculosis. New diagnostic tools like interferon-gamma release assays and the Xpert MTB/RIF nucleic acid test have improved TB diagnosis. A history of symptoms, risk factors, and test results together are used to diagnose TB.
Abdominal Tuberculosis final final.pptxmanjujanhavi
Abdominal tuberculosis is a common extra-pulmonary manifestation of tuberculosis. It can affect any part of the gastrointestinal tract, with the ileocecal region being the most common site. Presentations include intestinal obstruction, perforation, ascites, and masses. Diagnosis involves imaging such as x-ray, ultrasound and CT scan. Laboratory tests on ascitic fluid include ADA levels, smear and culture. Laparoscopy allows for biopsy and diagnosis. Treatment involves anti-tuberculosis medication alongside management of complications. Coinfection with HIV increases severity and risk of immune reconstitution inflammatory syndrome.
Abdominal tuberculosis is a common extra-pulmonary manifestation of tuberculosis. It can affect any part of the gastrointestinal tract, with the ileocecal region being the most common site. Presentations include intestinal obstruction, perforation, ascites, and masses. Diagnosis involves imaging such as x-ray, ultrasound and CT scan. Laboratory tests on ascitic fluid include ADA levels, smear and culture. Laparoscopy allows for biopsy and diagnosis. Treatment involves anti-tuberculosis medication alongside management of complications. Coinfection with HIV increases severity and risk of immune reconstitution inflammatory syndrome.
This document discusses tuberculosis of the hip. It begins by providing historical context, noting that Robert Koch discovered Mycobacterium tuberculosis in 1882. It then discusses the pathogenesis and presentation of hip TB. Key points include that hip TB is secondary to a primary focus that spreads hematogenously to the hip. Presenting symptoms often include pain and limping. The document outlines the typical pathology and stages of hip TB from synovitis to advanced arthritis and destruction of the joint. Diagnosis involves clinical, radiological, bacteriological and molecular testing. Management includes antitubercular therapy, rest, traction and sometimes surgical interventions like excision arthroplasty or joint replacement.
The document discusses the evaluation and diagnosis of pyrexia of unknown origin (PUO). It defines PUO and provides classifications. The most common causes are infections (30-40%), neoplasms (20-30%), and non-infectious inflammatory conditions (10-20%). The initial approach involves thorough history, physical exam, and basic lab tests. Further targeted testing is based on clues from initial evaluation and may include specialized cultures, biopsies, and imaging. The goal is to methodically consider and rule out more likely causes through an intensive diagnostic process to identify the underlying condition.
1. Clinical manifestations of paediatric tuberculosis can be non-specific and tuberculosis is more difficult to diagnose in children compared to adults. Children are more likely to develop severe or disseminated disease if tuberculosis is undiagnosed or untreated.
2. Diagnosis of tuberculosis in a child is a sentinel event that requires contact investigation to be critical.
3. Congenital tuberculosis transmission from mother to child is rare but carries high risks of neonatal mortality and morbidity, so early diagnosis and treatment of infected newborns is important.
Dr. W.A.P.S.R.Weerarathna defines pyrexia of unknown origin (PUO) as a temperature of ≥ 38.3°C on multiple occasions for ≥ 3 weeks without reaching a diagnosis. Common causes of PUO include infections (40%), malignancies (25%), and autoimmune diseases (15%). For classic PUO, the three most common etiologies are infections, malignancies, and collagen vascular diseases. A thorough history, physical exam, and initial laboratory/imaging tests are recommended to guide further targeted investigations. More invasive testing should only be done if indicated or if initial evaluation does not identify the source of fever.
This document discusses the approach to pyrexia of unknown origin (FUO) in children. It defines FUO and classifies it into four categories: classic FUO, healthcare-associated FUO, immune deficient FUO, and HIV-related FUO. For each category, it provides the definition, leading causes, aspects of history and examination to focus on, appropriate investigations, management considerations, and typical time course. It also discusses the various etiologies that can cause FUO and provides guidance on taking a thorough history, performing a physical examination, and selecting initial investigations. The key takeaway is that FUO may represent an uncommon manifestation of a common disease and the workup should be tailored thoughtfully to each case.
This document discusses various laboratory methods for diagnosing tuberculosis (TB), including:
- Sputum smear microscopy to detect acid-fast bacilli, the most common initial diagnostic method.
- Nucleic acid amplification tests like PCR and GeneXpert that can rapidly detect TB in sputum through DNA amplification.
- Culture-based methods grown on solid or liquid media to isolate Mycobacterium tuberculosis from clinical samples, which is then tested for drug susceptibility.
- Immunological tests like interferon-gamma release assays that detect TB infection by measuring T-cell responses to TB antigens.
It provides details on the principles, advantages, and limitations of different microbiological, molecular,
This document discusses tuberculosis (TB) in children. It begins with an overview of the clinical spectrum of TB in children, which can include pulmonary, visceral, cutaneous, neuro, and perinatal manifestations. Pulmonary TB lesions in children typically include primary complexes and intrathoracic lymphadenopathy. Extrapulmonary TB involves sites like bone, joints, the gastrointestinal tract, and the central nervous system. The document then covers the diagnosis of TB in children, which involves clinical judgment based on exposure history and symptoms, the tuberculin skin test, chest x-ray, and bacteriological confirmation via sputum sampling or gastric aspiration. Interpretation of diagnostic tests and their limitations are also discussed.
1. Pyrexia of unknown origin (PUO) is defined as a fever that persists for at least 3 weeks with an unknown source despite 1 week of inpatient investigations or 3 outpatient visits. (2) Common causes of PUO include infections (especially tuberculosis), malignancies, and collagen vascular diseases.
2. A thorough history, physical exam, and initial laboratory and imaging tests are used to identify potential sources and guide further testing. Additional tests may include lumbar puncture, bone marrow biopsy, liver biopsy, or exploratory laparotomy.
3. When the source remains unknown after extensive evaluation, infectious disease, rheumatology, or oncology consultations may help identify less common causes or guide further
1. Pyrexia of unknown origin (PUO) is defined as a fever that persists for at least 3 weeks with an unknown source despite 1 week of inpatient investigations or 3 outpatient visits. (2) Common causes of PUO include infections (especially tuberculosis), malignancies, and collagen vascular diseases.
2. A thorough history, physical exam, and initial laboratory and imaging tests are used to identify potential sources and guide further testing. Additional tests may include lumbar puncture, bone marrow biopsy, liver biopsy, or exploratory laparotomy.
3. When the source remains unknown after extensive evaluation, infectious disease, rheumatology, or oncology consultations may help identify less common causes or guide further
- Pulmonary tuberculosis is caused by infection with Mycobacterium tuberculosis or Mycobacterium bovis bacteria. It is transmitted through inhalation of droplets from an infected person.
- Diagnosis involves the Mantoux tuberculin skin test, sputum smears and cultures, and chest x-rays. Treatment depends on whether a person has latent infection, active disease, or a history of previous treatment.
- For new cases of active pulmonary TB, treatment typically involves two months of four drugs followed by four months of two drugs. For latent infection, nine months of isoniazid is usually recommended. Preventive therapy aims to reduce the risk of developing active TB in the future.
Pattern of inflammatory diseases in lymph node biopsyMusa Ezekiel
This document summarizes patterns of inflammatory diseases seen in lymph node biopsies at ABUTH, Zaria from 2006-2010. Tuberculosis (TB) was the most common diagnosis, making up 78% of cases. TB adenitis was most prevalent in adults ages 19-45 and more common in males. Chronic granulomatous disease, non-specific lymphadenitis, histoplasmosis, and toxoplasmosis were also identified. The review discusses the anatomy of lymph nodes, characteristics of different inflammatory diseases, and recommendations for diagnosis and treatment.
This document discusses fever of unknown origin (FUO). It begins by classifying FUO into categories like classical FUO and nosocomial FUO. It then discusses the epidemiology and common etiologies of FUO, which include infections, collagen vascular diseases, and malignancies. The diagnostic approach involves a thorough history, repeated physical exams, and diagnostic testing like blood tests, imaging, and biopsies. Empirical therapeutic drug trials can help diagnose certain conditions but have limitations. The prognosis depends on the underlying cause, with poorer outcomes seen in elderly patients or those with neoplasms or diagnostic delays.
This document summarizes information about neonatal sepsis, including its definition, risk factors, symptoms, diagnosis, and treatment. Key points include: neonatal sepsis is a bloodstream infection common in preterm infants, with symptoms that are non-specific; diagnosis relies on clinical assessment combined with laboratory tests like blood cell counts and blood cultures; and treatment involves early, broad-spectrum antibiotics along with supportive care while monitoring for complications. The document also discusses challenges around diagnosing sepsis in newborns and potential immunotherapy approaches.
Genital tuberculosis is a significant cause of infertility globally, affecting an estimated 8-10 million women. It commonly involves the fallopian tubes, causing scarring and blockages that impair fertility. Diagnosis is challenging due to the paucibacillary nature of the infection and low sensitivity of diagnostic tests. Investigations include histopathology of endometrial tissue, nucleic acid amplification tests, culture, and imaging. Treatment involves a prolonged course of anti-tuberculosis medications, with surgery reserved for complications. Fertility outcomes are generally poor due to permanent tubal damage, but IVF may offer an option for conceiving.
The document discusses tuberculosis (TB), caused by Mycobacterium tuberculosis. It notes that about 1/3 of the world's population is infected, with around 3 million deaths and 8 million new cases annually. TB is transmitted through airborne droplets and has an incubation period of 4-12 weeks. Diagnosis involves tests like sputum smear microscopy, culture, tuberculin skin test, chest x-ray, and PCR. Standard treatment includes isoniazid, rifampin, ethambutol and pyrazinamide for 2 months, followed by isoniazid and rifampin for 4 more months. Drug resistance is a major problem, with MDR-TB resistant to isoniazid
Neonatal sepsis is a serious infection that can affect newborns, especially those born prematurely or with low birth weight. The immaturity of a newborn's immune system makes them highly susceptible to infection. Symptoms of neonatal sepsis are non-specific and can include poor feeding, temperature instability, and respiratory distress. Diagnosis relies on clinical signs and abnormal laboratory test results, as there is no single diagnostic marker. Treatment involves administering broad-spectrum antibiotics early while infection is considered, with supportive care and management of any complications.
Diagnosis and managment of Fever of Unknown Originarahmanzai5
Fever of unknown origin (FUO) is defined as a fever over 38.3°C on at least two occasions lasting more than 3 weeks without a diagnosis. Common causes include infections such as endocarditis, malignancies such as lymphoma, and autoimmune disorders. The evaluation involves blood tests, imaging, and cultures to rule out common causes. If the cause remains unknown after initial testing, more invasive procedures like biopsy may be considered. Empiric treatment is generally avoided due to the risk of masking the underlying diagnosis, but may be considered in rapidly deteriorating patients. The prognosis is generally good, with most cases ultimately receiving a diagnosis and treatment.
This document provides information on spinal infections. It discusses two main types of spinal infections - pyogenic and non-pyogenic infections like tuberculosis. Pyogenic infections usually involve the lumbar spine and are caused by bacteria like Staph aureus. Tuberculosis is the most common non-pyogenic infection and usually affects the lower thoracic spine. Clinical features, investigations, management and various surgical approaches for treating spinal infections are described in detail.
This document discusses pyrexia of unknown origin (PUO). It begins by defining PUO according to old and new definitions. It then expands the new definition to include categories like nosocomial PUO, neutropenic PUO, and HIV-associated PUO. The document goes on to discuss the causes of PUO in different regions and time periods, with infectious diseases like tuberculosis being very common. It also outlines the evaluation and diagnostic approach for PUO, including relevant laboratory tests, physical exam findings, and potential etiologies.
This document discusses fever of unknown origin (FUO). It categorizes FUO into classical, nosocomial, neutropenic, and HIV-associated types. The most common etiologies of FUO are infections (30-60%), collagen vascular diseases (20-35%), and malignancies (10-20%). The diagnostic approach involves a careful history, physical exam, and diagnostic testing including blood tests, imaging, and biopsy. Empirical therapeutic drug trials may be used for suspected conditions like tuberculosis or culture-negative endocarditis, but have limitations and risks. The goal is to reach a specific diagnosis to guide appropriate treatment.
This document discusses pyrexia of unknown origin (PUO), defined as a fever above 38°C for more than 3 weeks without diagnosis. Common causes include infections (30%), malignancy (20%), and connective tissue disorders (15%). The document outlines an approach to evaluating PUO that involves obtaining a thorough history, conducting a physical exam focusing on potentially diagnostic clues, and performing initial obligatory tests before considering additional guided diagnostic tests if needed. Treatment is typically supportive while the underlying cause is determined. The overall mortality rate is high at 30-40% mainly due to malignancy, though fever often resolves spontaneously if no cause is found.
A 11-year-old female child was admitted to the hospital with fever, body aches, headache, abdominal pain, decreased appetite, and difficulty breathing for the past few days. On examination, she was tachypnic and hypoxic. Lab tests confirmed leptospirosis with organ dysfunction affecting the lungs, liver, kidneys, and brain. She required intensive care including mechanical ventilation, dialysis, and antibiotics. After 25 days in the hospital, she received a diagnosis of leptospirosis with multi-organ failure and intracranial hemorrhages.
Dr. W.A.P.S.R.Weerarathna defines pyrexia of unknown origin (PUO) as a temperature of ≥ 38.3°C on multiple occasions for ≥ 3 weeks without reaching a diagnosis. Common causes of PUO include infections (40%), malignancies (25%), and autoimmune diseases (15%). For classic PUO, the three most common etiologies are infections, malignancies, and collagen vascular diseases. A thorough history, physical exam, and initial laboratory/imaging tests are recommended to guide further targeted investigations. More invasive testing should only be done if indicated or if initial evaluation does not identify the source of fever.
This document discusses the approach to pyrexia of unknown origin (FUO) in children. It defines FUO and classifies it into four categories: classic FUO, healthcare-associated FUO, immune deficient FUO, and HIV-related FUO. For each category, it provides the definition, leading causes, aspects of history and examination to focus on, appropriate investigations, management considerations, and typical time course. It also discusses the various etiologies that can cause FUO and provides guidance on taking a thorough history, performing a physical examination, and selecting initial investigations. The key takeaway is that FUO may represent an uncommon manifestation of a common disease and the workup should be tailored thoughtfully to each case.
This document discusses various laboratory methods for diagnosing tuberculosis (TB), including:
- Sputum smear microscopy to detect acid-fast bacilli, the most common initial diagnostic method.
- Nucleic acid amplification tests like PCR and GeneXpert that can rapidly detect TB in sputum through DNA amplification.
- Culture-based methods grown on solid or liquid media to isolate Mycobacterium tuberculosis from clinical samples, which is then tested for drug susceptibility.
- Immunological tests like interferon-gamma release assays that detect TB infection by measuring T-cell responses to TB antigens.
It provides details on the principles, advantages, and limitations of different microbiological, molecular,
This document discusses tuberculosis (TB) in children. It begins with an overview of the clinical spectrum of TB in children, which can include pulmonary, visceral, cutaneous, neuro, and perinatal manifestations. Pulmonary TB lesions in children typically include primary complexes and intrathoracic lymphadenopathy. Extrapulmonary TB involves sites like bone, joints, the gastrointestinal tract, and the central nervous system. The document then covers the diagnosis of TB in children, which involves clinical judgment based on exposure history and symptoms, the tuberculin skin test, chest x-ray, and bacteriological confirmation via sputum sampling or gastric aspiration. Interpretation of diagnostic tests and their limitations are also discussed.
1. Pyrexia of unknown origin (PUO) is defined as a fever that persists for at least 3 weeks with an unknown source despite 1 week of inpatient investigations or 3 outpatient visits. (2) Common causes of PUO include infections (especially tuberculosis), malignancies, and collagen vascular diseases.
2. A thorough history, physical exam, and initial laboratory and imaging tests are used to identify potential sources and guide further testing. Additional tests may include lumbar puncture, bone marrow biopsy, liver biopsy, or exploratory laparotomy.
3. When the source remains unknown after extensive evaluation, infectious disease, rheumatology, or oncology consultations may help identify less common causes or guide further
1. Pyrexia of unknown origin (PUO) is defined as a fever that persists for at least 3 weeks with an unknown source despite 1 week of inpatient investigations or 3 outpatient visits. (2) Common causes of PUO include infections (especially tuberculosis), malignancies, and collagen vascular diseases.
2. A thorough history, physical exam, and initial laboratory and imaging tests are used to identify potential sources and guide further testing. Additional tests may include lumbar puncture, bone marrow biopsy, liver biopsy, or exploratory laparotomy.
3. When the source remains unknown after extensive evaluation, infectious disease, rheumatology, or oncology consultations may help identify less common causes or guide further
- Pulmonary tuberculosis is caused by infection with Mycobacterium tuberculosis or Mycobacterium bovis bacteria. It is transmitted through inhalation of droplets from an infected person.
- Diagnosis involves the Mantoux tuberculin skin test, sputum smears and cultures, and chest x-rays. Treatment depends on whether a person has latent infection, active disease, or a history of previous treatment.
- For new cases of active pulmonary TB, treatment typically involves two months of four drugs followed by four months of two drugs. For latent infection, nine months of isoniazid is usually recommended. Preventive therapy aims to reduce the risk of developing active TB in the future.
Pattern of inflammatory diseases in lymph node biopsyMusa Ezekiel
This document summarizes patterns of inflammatory diseases seen in lymph node biopsies at ABUTH, Zaria from 2006-2010. Tuberculosis (TB) was the most common diagnosis, making up 78% of cases. TB adenitis was most prevalent in adults ages 19-45 and more common in males. Chronic granulomatous disease, non-specific lymphadenitis, histoplasmosis, and toxoplasmosis were also identified. The review discusses the anatomy of lymph nodes, characteristics of different inflammatory diseases, and recommendations for diagnosis and treatment.
This document discusses fever of unknown origin (FUO). It begins by classifying FUO into categories like classical FUO and nosocomial FUO. It then discusses the epidemiology and common etiologies of FUO, which include infections, collagen vascular diseases, and malignancies. The diagnostic approach involves a thorough history, repeated physical exams, and diagnostic testing like blood tests, imaging, and biopsies. Empirical therapeutic drug trials can help diagnose certain conditions but have limitations. The prognosis depends on the underlying cause, with poorer outcomes seen in elderly patients or those with neoplasms or diagnostic delays.
This document summarizes information about neonatal sepsis, including its definition, risk factors, symptoms, diagnosis, and treatment. Key points include: neonatal sepsis is a bloodstream infection common in preterm infants, with symptoms that are non-specific; diagnosis relies on clinical assessment combined with laboratory tests like blood cell counts and blood cultures; and treatment involves early, broad-spectrum antibiotics along with supportive care while monitoring for complications. The document also discusses challenges around diagnosing sepsis in newborns and potential immunotherapy approaches.
Genital tuberculosis is a significant cause of infertility globally, affecting an estimated 8-10 million women. It commonly involves the fallopian tubes, causing scarring and blockages that impair fertility. Diagnosis is challenging due to the paucibacillary nature of the infection and low sensitivity of diagnostic tests. Investigations include histopathology of endometrial tissue, nucleic acid amplification tests, culture, and imaging. Treatment involves a prolonged course of anti-tuberculosis medications, with surgery reserved for complications. Fertility outcomes are generally poor due to permanent tubal damage, but IVF may offer an option for conceiving.
The document discusses tuberculosis (TB), caused by Mycobacterium tuberculosis. It notes that about 1/3 of the world's population is infected, with around 3 million deaths and 8 million new cases annually. TB is transmitted through airborne droplets and has an incubation period of 4-12 weeks. Diagnosis involves tests like sputum smear microscopy, culture, tuberculin skin test, chest x-ray, and PCR. Standard treatment includes isoniazid, rifampin, ethambutol and pyrazinamide for 2 months, followed by isoniazid and rifampin for 4 more months. Drug resistance is a major problem, with MDR-TB resistant to isoniazid
Neonatal sepsis is a serious infection that can affect newborns, especially those born prematurely or with low birth weight. The immaturity of a newborn's immune system makes them highly susceptible to infection. Symptoms of neonatal sepsis are non-specific and can include poor feeding, temperature instability, and respiratory distress. Diagnosis relies on clinical signs and abnormal laboratory test results, as there is no single diagnostic marker. Treatment involves administering broad-spectrum antibiotics early while infection is considered, with supportive care and management of any complications.
Diagnosis and managment of Fever of Unknown Originarahmanzai5
Fever of unknown origin (FUO) is defined as a fever over 38.3°C on at least two occasions lasting more than 3 weeks without a diagnosis. Common causes include infections such as endocarditis, malignancies such as lymphoma, and autoimmune disorders. The evaluation involves blood tests, imaging, and cultures to rule out common causes. If the cause remains unknown after initial testing, more invasive procedures like biopsy may be considered. Empiric treatment is generally avoided due to the risk of masking the underlying diagnosis, but may be considered in rapidly deteriorating patients. The prognosis is generally good, with most cases ultimately receiving a diagnosis and treatment.
This document provides information on spinal infections. It discusses two main types of spinal infections - pyogenic and non-pyogenic infections like tuberculosis. Pyogenic infections usually involve the lumbar spine and are caused by bacteria like Staph aureus. Tuberculosis is the most common non-pyogenic infection and usually affects the lower thoracic spine. Clinical features, investigations, management and various surgical approaches for treating spinal infections are described in detail.
This document discusses pyrexia of unknown origin (PUO). It begins by defining PUO according to old and new definitions. It then expands the new definition to include categories like nosocomial PUO, neutropenic PUO, and HIV-associated PUO. The document goes on to discuss the causes of PUO in different regions and time periods, with infectious diseases like tuberculosis being very common. It also outlines the evaluation and diagnostic approach for PUO, including relevant laboratory tests, physical exam findings, and potential etiologies.
This document discusses fever of unknown origin (FUO). It categorizes FUO into classical, nosocomial, neutropenic, and HIV-associated types. The most common etiologies of FUO are infections (30-60%), collagen vascular diseases (20-35%), and malignancies (10-20%). The diagnostic approach involves a careful history, physical exam, and diagnostic testing including blood tests, imaging, and biopsy. Empirical therapeutic drug trials may be used for suspected conditions like tuberculosis or culture-negative endocarditis, but have limitations and risks. The goal is to reach a specific diagnosis to guide appropriate treatment.
This document discusses pyrexia of unknown origin (PUO), defined as a fever above 38°C for more than 3 weeks without diagnosis. Common causes include infections (30%), malignancy (20%), and connective tissue disorders (15%). The document outlines an approach to evaluating PUO that involves obtaining a thorough history, conducting a physical exam focusing on potentially diagnostic clues, and performing initial obligatory tests before considering additional guided diagnostic tests if needed. Treatment is typically supportive while the underlying cause is determined. The overall mortality rate is high at 30-40% mainly due to malignancy, though fever often resolves spontaneously if no cause is found.
A 11-year-old female child was admitted to the hospital with fever, body aches, headache, abdominal pain, decreased appetite, and difficulty breathing for the past few days. On examination, she was tachypnic and hypoxic. Lab tests confirmed leptospirosis with organ dysfunction affecting the lungs, liver, kidneys, and brain. She required intensive care including mechanical ventilation, dialysis, and antibiotics. After 25 days in the hospital, she received a diagnosis of leptospirosis with multi-organ failure and intracranial hemorrhages.
Similar to Presentation on Hepato-Billiary TB | Jindal Chest Clinic (20)
Thrombo-prophylaxis in Critical Care | Jindal chest clinicJindal Chest Clinic
Thrombo-prophylaxis used in critically ill patients who are either bleeding or are at high risk for bleeding. This presentationby Dr. Aditya Jindal on "Thrombo-prophylaxis in Critical Care". For more information, please contact: 9779030507.
Interstitial lung disease (ILD) is a group of diseases causing fibrosis in the lungs, leading to stiffness and difficulty in breathing and oxygen delivery to the bloodstream. This presentation gives an overview on "Diagnosis of ILD". For more information, please contact us: 9779030507.
Physiology of the Respiratory System | Jindal chest clinicJindal Chest Clinic
Respiratory system is the system in which the organs and structures in body that allow to breathe. This presentation gives an overview on "Physiology of the Respiratory System" including: non respiratory functions, air conditioning, warming and humidfying, immune functions, functions of cilia, metabolic functions, etc. For more information please contact us: 9779030507.
Molecular Diagnosis of Tuberculosis by Dr. Aditya Jindal | Jindal Chest ClinicJindal Chest Clinic
Analyzing DNA or RNA sequences to spot warning signs of possible diseases is the process of molecular diagnostics, commonly referred to as molecular pathology. This presentation by Dr. Aditya Jindal, gives an overview on "Molecular Diagnosis of Tuberculosis". For more information, please contact us: 9779030507.
A difficult airway is a clinical situation in which a medical professional with training in airway management finds it difficult to use the recommended techniques. This presentation gives an overview on the topic "Difficult airway Management" including: difficult mask ventilation, preoxygenation, thyromental distance, laryngoscopy, cricothirotomy, etc. For more information, please contact us: 9779030507.
Difficult airway in ICU by Dr. Aditya Jindal | JIndal Chest ClinicJindal Chest Clinic
A difficult airway is a clinical situation in which a medical professional with training in airway management finds it difficult to use the recommended techniques. This presentation gives an overview on the topic "Difficult airway in ICU". For more information, please contact us: 9779030507.
Tuberculosis pathophysiology and diagnosis | Jindal Chest ClinicJindal Chest Clinic
Tuberculosis is an infectious lung disease caused by bacteria, spreading through the air through coughing, sneezing, or spit. It is preventable and curable. This presentation gives an overview on "Tuberculosis pathophysiology and diagnosis". For more information, please contact us: 9779030507.
Silicosis in India: Defining the problem and developing solutions | By Dr. S....Jindal Chest Clinic
Silicosis is a lung disease caused by inhaling small particles of silica, a common mineral found in sand, quartz, and rock, primarily affecting workers in construction and mining industries. For more information, please contact us: 9779030507.
Overview on "Pulmonary Vasculitis" including its: symptoms, diagnosis, pathology, risk factors, management, treatment, etc. For more information, please contact us: 9779030507.
Treatment of ILDs by Dr. S.K Jindal | JIndal Chest ClinicJindal Chest Clinic
Interstitial lung disease (ILD) refers to a variety of diseases causing fibrosis in the lungs, leading to stiffness and difficulty in breathing and oxygen delivery to the bloodstream. This presentation gives an overview on "Treatment of ILD". For more information, please contact us: 9779030507.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
6. Genital TB - Males
TB of testes, epididymis, prostate,
penis, urethra
S/S: Hemospermia
Scrotal pain and swelling
Nodularity of epididymis, vas
deferens, prostate
Sometimes, sinus formation; perineal fistula
7. Genital TB - Females
Fallopian tubes – common
Endometrial
Ovarian
Cervix, vagina, vulva
S & S: Ch. lower abd. pain
abnormal discharge
Altered menses
Infertility
Tubo-ovarian masses, ascites, adhesions etc.
8. Skeletal TB
Most ancient form – pre-historic
Hematogenous spread
Involves spine and other bones – hip joint, knee, ankle, foot bones etc.
Types:
Osseus granular (Metaphysis or epiphysis)
Osseus caseus
Synovial granular
Synovial caseus
9. Spinal TB
Lower thoracic and lumbar vertebrae
Infection begins in cancellous area of vertebral body – destruction –
collapse of vertebra
Exudation – cold abscess
Symptoms of local compression from cold abscess
Spinal: paraparesis – plegia
Mediastinal structures
Psoas abscess
10. Pott’s paraplegia - Mechanism
i. Extrinsic or mechanical causes
Cold abscess
Granulation tissue
Sequestrated bone and disc
Fibrous tissue
Gliosis of spinal cord
ii. Intrinsic or non-mechanical causes
TB inflammation (spinal meningitis)
Thrombosis of ant. spinal artery
23. Diagnosis of Pulmonary TB
Clinical Features
Sputum Examination
Chest Radiology
Bronchoscopy
Mantoux test
Indirect laboratory tests
24. Radiological Characteristics
I. Chest: Upper Lobes/Diffuse miliary
Infiltrates/Exudates/Fibrosis
Multiple, thin walled cavities
Lymphadenopathy, Pl.effusion
II. Others: Enlargement of organs
Erosions/Effusions
Caseations/collections
25.
26.
27.
28. Role of Chest X-ray
No chest X-ray pattern is absolutely typical of TB
10-15% of culture-positive TB patients not diagnosed by X-ray
40% of patients diagnosed as having TB on the basis of x-ray alone do
not have active TB
X-ray is unreliable for diagnosing and monitoring treatment of
tuberculosis
29. Role of bronchoscopy
Valuable in early diagnosis of strongly suspected sputum-
negative TB.
Diagnosis of endobronchial TB/miliary TB
TBLB yield is greater (82%) than BAL (26%)
TBNA has a role in mediastinal lymph nodal tuberculosis
with negative sputum smears
31. Tuberculin (Mantoux) Test
Infection with mycobacterium tuberculosis leads delayed
hypersensitivity reaction which can be detected by Mantoux test
About 2 to 4 weeks after infection, intracutaneous injection of
purified protein derivative (PPD) of M.tuberculosis induces a
visible and palpable induration that peaks in 48 to 72 hours
32. How to do the test?
Sub cutaneous
Weal formation
Itching – no scratch.
Read after 72 hours.
Induration size.
5-10-15mm
33. Mx Interpretation
(i) Induration less than 5 mm – no exposure to tubercular bacilli.
(ii) Induration between 5-9 mm – this can be due to atypical
mycobacteria or BCG vaccination. It may suggest infection in
immunocompromised children such as HIV infection or other
immunosupression;
(iii) Induation 10 mm or more – an induration of 10 mm or more at
48-72 hours in a child with symptoms of tuberculosis should be
interpreted as tubercular disease
35. Clinical significance
Denotes infection
Does not differentiate infection from active disease
A strongly positive Mantoux can support a clinical diagnosis
Better negative than positive predictive value
Cut-off for a positive test?
36. Tests for mycobac aetiology
i. Smear examination
ii. Culture for mycobacteria
LJ medium
Rapid culture methods
iv. Nucleic acid amplification tests
Polymerase chain reaction
37. Mycobacterial demonstration
Samples to be tests
Sputum, induced sputum
Fiberoptic bronchoscopy – BAL
Bronchial or transbronchial
lung biopsy
Gastric lavage (Children)
Pleural fluid
40. Indirect Tests: Markers
1. Biochemical: LDH, Proteins
Adenosine Deaminase
Bromide Partition Test
Gas Chromatography – Fatty acids, alcohols etc.
2. Immuno-diagnosis
Skin test (Mantoux)
Detection of Antibodies (Tests banned)
41. Serological Tests
Low turn around time.
Limitation: low sensitivity in:
smear negative patients, HIV positive cases,
in disease -endemic countries with a high infection rate.
Poor standardization.
Banned in 2012.
42. Newer Tests
Gamma Interferon Assay Test
(Gold – IGRA)
Genetic/Molecular techniques
Gene X-pert TB
Detection of DNA specific base sequences
DNA amplification and detection
RNA: Presence of multiplying bacteria
43. An alternative to the TST in the form of a new type of in-vitro T-cell-
based assay
(Test-tube TST)
Gold IGRA
Elispot T test
T cells of individuals sensitized with tuberculosis antigens produce
interferon-γ when they re-encounter mycobacterial antigens
High level of interferon-γ production - presumptive of tuberculosis
infection
44. In the absence of a gold standard for diagnosis of Latent TBI,
the sensitivity and specificity cannot be directly estimated
IGRA have higher specificity than TST
Better correlation with surrogate markers of exposure to M
tuberculosis
(in low-incidence setting countries)
Less cross reactivity as a result of BCG vaccination than TST
45. Gene X-pert Test
Detection and identification of mycobacteria
directly from clinical samples
Cartridge based, PCR test for detection of mycobacteria and
Rifampicin resistance
Rapid test. Results within hours.
Costly
Continuous electric supply and temperature maintenance
? Field feasibility, sensitivity and specificity
in India.
46. Confirmation of diagnosis of Pulm TB
Clinical features are not confirmatory.
Zeil Nielson Stain
Culture most sensitive and specific test.
Conventional Lowenstein Jensen media 3-6 wks.
Automated techniques within 9-16 days
PCR is available, but should only be performed by experienced
laboratories
Mantoux test
47. Diagnosis of Extra Pulmonary TB
Sputum or other smears are often Negative. These are difficult to use for
Diagnosis and start of treatment
Follow up
Monitoring
End point
Recurrence / Relapse
Mostly clinico-radio-histo/cytological
Invasive procedures frequently required to obtain tissue, fluids, etc. to
look for T.b. and/or histo-cytological criteria.
48. Difficulties of Extra-pulmonary Tuberculosis
Largely clinical and radiological.
Supported by laboratory parameters and other TB markers.
Invasive procedures frequently required to obtain tissue, fluids,
etc. to look for T.b. and/or histo-cytological criteria.
Therapeutic trial as a diagnostic modality should not be used.